GAVRETO

Identification of Gavreto

No description

Google image searchProduct monograph

Active ingredient

pralsetinib, 100 MG

DIN: 02517590

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Schedule: Prescription

Company: HOFFMANN-LA ROCHE LIMITED

Date: 12-NOV-2021

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
• L01EX — Other protein kinase inhibitors (ATC, ATC/DDD)
• L01EX23 — PRALSETINIB (ATC/DDD)

External Links for Gavreto

Search on Google

• Gavreto side effects
• Gavreto dosage
• pralsetinib side effects
• pralsetinib dosage

Hoffmann-La Roche Limited

Go to Hoffmann-La Roche website to see drug product details. Sometimes you can find gavreto photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.